The race to develop powerful new weight-loss drugs grew even more heated on Thursday as Roche Holding AG released early-stage trial results for an experimental obesity treatment. The once-weekly ...

Darragh Roche is a U.S. News Reporter based in Limerick, Ireland. His focus is reporting on U.S. politics. He has covered the Biden administration, election polling and the U.S. Supreme Court.

By posing questions, answers from interviews conducted with Speranza and other veterans can be played, preserving not just the stories of World War II, but also the people who lived them.

Whether you’ve visited a dermatologist at the office, perused the drugstore skincare aisle or scrolled on #BeautyTok, you’ve likely been recommended to try La Roche-Posay. And, rightfully so ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Viking Therapeutics (NASDAQ:VKTX) was a notable decliner among anti-obesity drug developers on Thursday after Swiss pharma giant Roche (OTCQX:RHHBY) said its dual GLP-1/GIP receptor agonist ...

It was Queen Elizabeth II’s unchanging nature, epitomized by her unbending adherence to the royals’ unofficial motto of “Never complain, never explain” that made her a constant fixture in ...

Thursday, Genentech, a unit of Roche Holdings AG (OTC:RHHBY), released results from the Phase 1b trial of CT-388, a dual GLP-1/GIP receptor agonist being developed for the treatment of obesity and ...

Nobul AI Corp. ("Nobul") and Check-Cap Ltd. ("Check-Cap" or the "Company") (NASDAQ: CHEK) today announced that they have entered into a definitive Business Combination Agreement (the "Business ...